We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going ...

Biogen has offered to purchase Sage’s outstanding shares for $7.22 each, according to a securities filing from Friday. The proposal values Sage at around $442 million. A yearslong partner of ...

Building tools for clinicians The explosion ... So, another effort from Biogen is a web-platform and app they’ve developed called Neurodiem, which helps CNS specialists specifically keep up ...

The proposed merger of the two Cambridge drugmakers is off, but Sage says it's open to "strategic alternatives" — including a sale. Sage Therapeutics Inc. is looking for a deal — but it’s ...

Jan 10 (Reuters) - Drugmaker Biogen (BIIB.O), opens new tab will buy all outstanding shares of Sage Therapeutics (SAGE.O), opens new tab that it does not already own for $7.22 apiece, a filing ...

Makers 1 Building Jawahar Road, Rajkot, Gujarat, 360001, 91-79-27498832, 91-79-26765463. The main industry in which Biogen Pharmachem Industries Ltd operates is Finance & Investments. Auditor ...

In this article, we are going to take a look at where Biogen Inc. (NASDAQ ... which posted a gain of 23.31%, building on the 24.2% return in 2023. The two-year surge of over 53% is the best ...